FERRO THERAPEUTICS INC has a total of 19 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are TECNIMEDE SOC TECNICO MEDICINAL SA, SELDAR PHARMA INC and NANJING INNOCARE PHARMA TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | United States | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Taiwan | 2 | |
#5 | Argentina | 1 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | China | 1 | |
#10 | Israel | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Jiang Chun | 17 |
#2 | Chen Ruihong | 16 |
#3 | Kalita Biswajit | 15 |
#4 | Pandey Anjali | 15 |
#5 | Duraiswamy Athisayamani Jeyaraj | 13 |
#6 | Ruihong Chen | 1 |
#7 | Duraiswamy Athisayamani | 1 |
#8 | Athisayamani Jeyaraj Duraiswamy | 1 |
#9 | Anjali Pandey | 1 |
#10 | Biswajit Kalita | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021041539A2 | Pyrido-indole analogues as gpx4 inhibitors | |
WO2021041536A1 | Benzimidazole and hydrogenated carbazole derivatives as gpx4 inhibitors | |
US2020299283A1 | Compounds and methods of use | |
TW202045480A | Compounds and methods of use | |
AU2019229256A1 | Compounds with ferroptosis inducing activity and methods of their use | |
US2020138829A1 | Methods of cancer treatment |